Shu G. Chen, PhD

Pathology Case Western Reserve University, Cleveland Heights, OH, United States 
"Shu Chen"
Cross-listing: Neurotree

BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Wang Q, Davis PB, Qi X, et al. (2021) Gut-microbiota-microglia-brain interactions in Alzheimer's disease: knowledge-based, multi-dimensional characterization. Alzheimer's Research & Therapy. 13: 177
Zheng C, Fillmore NR, Ramos-Cejudo J, et al. (2021) Potential long-term effect of tumor necrosis factor inhibitors on dementia risk: A propensity score matched retrospective cohort study in US veterans. Alzheimer's & Dementia : the Journal of the Alzheimer's Association
Schaffner A, Li X, Gomez-Llorente Y, et al. (2019) Vitamin B modulates Parkinson's disease LRRK2 kinase activity through allosteric regulation and confers neuroprotection. Cell Research
Yan T, Wang L, Gao J, et al. (2018) Rab10 Phosphorylation is a Prominent Pathological Feature in Alzheimer's Disease. Journal of Alzheimer's Disease : Jad
Cracco L, Notari S, Cali I, et al. (2017) Novel strain properties distinguishing sporadic prion diseases sharing prion protein genotype and prion type. Scientific Reports. 7: 38280
Chen SG, Stribinskis V, Rane MJ, et al. (2016) Exposure to the Functional Bacterial Amyloid Protein Curli Enhances Alpha-Synuclein Aggregation in Aged Fischer 344 Rats and Caenorhabditis elegans. Scientific Reports. 6: 34477
Johnson WM, Golczak M, Choe K, et al. (2016) Regulation of DJ-1 by glutaredoxin 1 in vivo - implications for Parkinson's disease. Biochemistry
Johnson WM, Wilson-Delfosse AL, Chen SG, et al. (2015) The roles of redox enzymes in Parkinson's disease: Focus on glutaredoxin. Therapeutic Targets For Neurological Diseases. 2
Safar JG, Xiao X, Kabir ME, et al. (2015) Structural determinants of phenotypic diversity and replication rate of human prions. Plos Pathogens. 11: e1004832
Johnson WM, Yao C, Siedlak SL, et al. (2015) Glutaredoxin deficiency exacerbates neurodegeneration in C. elegans models of Parkinson's disease. Human Molecular Genetics. 24: 1322-35
See more...